dc.contributor.author | Santonastaso, Massimo | |
dc.contributor.author | Uresin, Yagiz | |
dc.contributor.author | Schpe, Diethelm | |
dc.contributor.author | Ibram, Ghionul | |
dc.contributor.author | Tang, Hui | |
dc.contributor.author | Satlin, Andrew | |
dc.contributor.author | Taylor, Addison A. | |
dc.contributor.author | Kilo, Cbarles | |
dc.date.accessioned | 2021-03-05T15:27:24Z | |
dc.date.available | 2021-03-05T15:27:24Z | |
dc.date.issued | 2007 | |
dc.identifier.citation | Uresin Y., Taylor A. A. , Kilo C., Schpe D., Santonastaso M., Ibram G., Tang H., Satlin A., "Efficacy and safety of the direct renin inhibitor aliskiren and ramipril alone or in combination in patients with diabetes and hypertension", JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, cilt.8, ss.190-198, 2007 | |
dc.identifier.issn | 1470-3203 | |
dc.identifier.other | av_bc03e594-8983-4302-a737-c2eff3eff977 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/124980 | |
dc.identifier.uri | https://doi.org/10.3317/jraas.2007.028 | |
dc.description.abstract | Objective. To assess the antihypertensive efficacy and safety of the combination of the direct renin inhibitor aliskiren and ramipril in patients with diabetes and hypertension. | |
dc.language.iso | eng | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Sağlık Bilimleri | |
dc.subject | PERİFERAL VASKÜLER HASTALIĞI | |
dc.subject | Klinik Tıp | |
dc.subject | Tıp | |
dc.title | Efficacy and safety of the direct renin inhibitor aliskiren and ramipril alone or in combination in patients with diabetes and hypertension | |
dc.type | Makale | |
dc.relation.journal | JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM | |
dc.contributor.department | Novartis , , | |
dc.identifier.volume | 8 | |
dc.identifier.issue | 4 | |
dc.identifier.startpage | 190 | |
dc.identifier.endpage | 198 | |
dc.contributor.firstauthorID | 33235 | |